Christopher Liu
Stock Analyst at Leerink Partners
(3.18)
# 905
Out of 4,667 analysts
4
Total ratings
100%
Success rate
65.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Christopher Liu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Downgrades: Market Perform | $41 → $27 | $26.58 | +1.59% | 2 | Nov 5, 2024 | |
| NUVL Nuvalent | Initiates: Market Perform | $42 | $93.52 | -55.09% | 1 | Aug 8, 2023 | |
| EXEL Exelixis | Initiates: Market Perform | $18 | $34.85 | -48.34% | 1 | Aug 8, 2023 |
IDEAYA Biosciences
Nov 5, 2024
Downgrades: Market Perform
Price Target: $41 → $27
Current: $26.58
Upside: +1.59%
Nuvalent
Aug 8, 2023
Initiates: Market Perform
Price Target: $42
Current: $93.52
Upside: -55.09%
Exelixis
Aug 8, 2023
Initiates: Market Perform
Price Target: $18
Current: $34.85
Upside: -48.34%